P3 Health Partners Inc.
Calidad de datos: 100%
$2.36
▼
$0.18
(-7.09%)
Cap. Mercado: 537.14 M
Precio
$2.64
Cap. Mercado
537.14 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—
Quick Summary
Puntos Clave
Negative free cash flow of -122.87 M
Capital efficient — spends only 0.01% of revenue on capex
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)18.48%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-1016.92%
Below sector avg (-15.95%)
ROIC-82.75%
Net Margin-9.07%
Op. Margin-17.64%
Seguridad
Debt / Equity
N/A
Current Ratio0.32
Interest Coverage-5.51
Valoración
PE (TTM)
-4.10
Below sector avg (-1.19)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Services (515 pares)
Comparación con Pares
vs mediana del sector Services (515 pares)| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -4.1 | -1.2 |
| P/B | — | 1.4 |
| ROE % | -1016.9 | -16.0 |
| Net Margin % | -9.1 | -18.3 |
| Rev Growth 5Y % | — | 3.8 |
| D/E | — | 0.4 |
Precio Objetivo de Analistas
2 analistas
Buy
Actual
$2.36
Objetivo
$3.50
$3.00
$3.50
$4.00
Pronóstico
EPS Futuro
-$2.57
Ingresos Est.
1.60 B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2027 |
-$2.57
-$2.57 – -$2.57
|
1.60 B | 1 |
| FY2026 |
-$9.44
-$10.29 – -$8.58
|
1.55 B | 2 |
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| 2026 Q2 |
-$1.97
-$2.03 – -$1.91
|
384.10 M | 2 |
| 2026 Q1 |
-$3.51
-$3.73 – -$3.28
|
398.20 M | 2 |
Sorpresas de Ganancias
Últimos 4 trimestres
| Trimestre | EPS Est. | EPS Real | Sorpresa |
|---|---|---|---|
| Q42025 | -$9.47 | -$23.02 | -143.2% |
| Q32025 | -$6.04 | -$9.67 | -60.2% |
| Q22025 | -$4.30 | -$6.23 | -44.9% |
| Q12025 | -$7.92 | -$6.28 | +20.7% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 18.48% | Revenue Growth (3Y) | 405.31% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.44 B | Net Income (TTM) | -131.05 M |
| ROE | -1016.92% | ROA | -18.52% |
| Gross Margin | N/A | Operating Margin | -17.64% |
| Net Margin | -9.07% | Free Cash Flow (TTM) | -122.87 M |
| ROIC | -82.75% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.32 |
| Interest Coverage | -5.51 | Asset Turnover | 2.04 |
| Working Capital | -288.32 M | Tangible Book Value | -531.60 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -4.10 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 0.37 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 0.34 | Fwd Earnings Yield | N/A |
| FCF Yield | -22.87% | ||
| Market Cap | 537.14 M | Enterprise Value | 752.34 M |
| Per Share | |||
| EPS (Diluted TTM) | -22.62 | Revenue / Share | 7.11 |
| FCF / Share | -0.60 | OCF / Share | -0.60 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 0.01% | FCF Conversion | 93.76% |
| SBC-Adj. FCF | -129.31 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2023 | FY2021 | FY2022 |
|---|---|---|---|---|
| Revenue | 1.50 B | 1.27 B | 58.76 M | 1.05 B |
| Net Income | -135.85 M | -57.77 M | -10.08 M | -270.13 M |
| EPS (Diluted) | -1.08 | -0.63 | -0.24 | -6.50 |
| Gross Profit | — | — | — | — |
| Operating Income | -320.66 M | -167.93 M | -58.89 M | -1.56 B |
| EBITDA | — | — | — | — |
| R&D Expenses | — | — | — | — |
| SG&A Expenses | — | — | — | — |
| D&A | 86.06 M | 86.68 M | 187,558.0 | 87.29 M |
| Interest Expense | -22.17 M | -15.99 M | -1.32 M | -11.40 M |
| Income Tax | 4.39 M | 2.70 M | 0.0 | 1.86 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2023 | FY2021 | FY2022 |
|---|---|---|---|---|
| Total Assets | 783.42 M | 860.97 M | 2.36 B | 876.57 M |
| Total Liabilities | 633.89 M | 427.31 M | 299.94 M | 353.91 M |
| Shareholders' Equity | 75.94 M | 142.13 M | 273.55 M | 5.85 M |
| Total Debt | 89.82 M | 108.32 M | 83.62 M | 98.00 M |
| Cash & Equivalents | 38.82 M | 36.32 M | 140.48 M | 17.54 M |
| Current Assets | 184.14 M | 166.02 M | 199.86 M | 100.69 M |
| Current Liabilities | 496.42 M | 299.37 M | 198.77 M | 241.66 M |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#81 of 245
Actividad Reciente
Entró
Price/Sales Ratio Focus (Ken Fisher)
Apr 12, 2026
{"event":"ticker_viewed","properties":{"ticker":"PIII","listing_kind":"stock","pathname":"/stocks/piii","exchange":"NASDAQ","country":"US"}}